Soluble cyclic analogues of β amyloid peptide

US7342091B2 · kind B2 · utility

Assignee

• Max-Planck-Gesellschaft zur Föderung der Wissenschaften e.V. · US

Inventors

• Afroditi Kapurniotu · Aachen, DE
• Jurgen Bernhagen · Tübingen, DE
• Herwig Brunner · Stuttgart, DE

Key dates

• Filing date: Dec 21, 2001
• Grant date: Mar 11, 2008
• Expiry date: Dec 21, 2021

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention concerns a peptide having the biological activity of an inhibitor of amyloid formation and its diagnostic and medical use.